HHM Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

HHM Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Buy	+6	New	+$2.66K	﹤0.01%	783

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

HHM Wealth Advisors's VRTX Position: Q2 2026 in Review

HHM Wealth Advisors opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 6 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #783 among its holdings.

522 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

HHM Wealth Advisors held 6 shares of Vertex Pharmaceuticals worth $2.98K as of Q2 2026.
Vertex Pharmaceuticals was a new HHM Wealth Advisors position in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #783 holding.
522 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.